Nugenerex Immuno-oncology, Inc. Increase (Decrease) in Contract with Customer, Liability
Nugenerex Immuno-oncology, Inc. reported Increase (Decrease) in Contract with Customer, Liability of $6.30 million for the 9-month period ending 2021-04-30, per its 10-Q filed 2021-06-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-06-14
- 2021-04-30: Increase (Decrease) in Contract with Customer, Liability 9 month $6.30M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 9 month |
|---|---|
| 2021-04-30 | $6.30M 10-Q · filed 2021-06-14 |